Fig. 1From: MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trialRepresentation of the expected effects of MSC treatment on primary and secondary outcome measures.Back to article page